icon-    folder.gif   Conference Reports for NATAP  
  Conference on Retroviruses
and Opportunistic Infections (CROI)
Boston, Massachusetts
March 4-7, 2018
Back grey_arrow_rt.gif
DolPHIN-1: Dolutegravir vs Efavirenz when Initiating Treatment in Late Pregnancy
  Reported by Jules Levin
CROI 2018 March 4-7 Boston, MA
Waitt CJ1,2, Walimbwa SI2, Orrell C3, Lamorde M2, Heiberg C3, Mehta U4, KabogozzaJP2, Coombs JA3, ByamugishaJ5, Gini J1, Kintu K2, Amara A1, MalabaT4, Else LJ1, Myer L4, Khoo SH1for the DolPHIN-1 Study Group 1Department of Molecular and Clinical Pharmacology, University of Liverpool, UK 2 Infectious Diseases Institute, MakerereUniversity College of Health Sciences, Uganda 3 Desmond Tutu HIV Foundation, Cape Town, South Africa 4 University of Cape Town, South Africa 5 Department of Obstetrics and Gynaecology, Makerere University College of Health Sciences, Kampala, Uganda